| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $491K | -80.3% | -78.0% |
| Cost of Revenue | $1.4M | +1.1% | -17.5% |
| Gross Profit | -$932K | -186.1% | -283.3% |
| R&D Expense | $140K | -9.8% | -3.3% |
| SG&A Expense | $608K | +402.4% | +151.1% |
| Operating Income | -$1.7M | -308.3% | -1476.3% |
| Pre-tax Income | -$1.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $3.3M | -8.6% | +1479.2% |
| Inventory | $1.3M | -36.5% | -28.2% |
| Current Assets | $7.3M | +10.0% | +96.0% |
| Total Assets | $27.6M | -5.7% | +1.8% |
| Current Liabilities | $12.3M | -0.7% | -10.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $255K | — | — |
| Capital Expenditures | $208K | — | — |
| Investing Cash Flow | -$208K | — | — |
| Financing Cash Flow | $1.6M | — | — |
| Free Cash Flow | $46K | — | — |
| -345.9% |
| — |
| Net Income | -$1.3M | -355.4% | -5924.6% |
| EPS (Basic) | -$0.02 | -300.0% | -300.0% |
| EPS (Diluted) | -$0.02 | -300.0% | -300.0% |
| $14.3M |
| -1.0% |
| -4.5% |
| Stockholders' Equity | $9.8M | -10.7% | +9.0% |